The global MedSafetyWeek runs from 7 to 13 November 2022. During this annual social media campaign, the FAMHP is also encouraging everyone to report suspected adverse reactions to medicinal products.
The seventh edition of the annual #MedSafetyWeek, launched today by the Federal Agency for Medicines and Health Products (FAMHP) in Belgium, runs until 13 November 2022 and invites everyone to report suspected adverse reactions to medicinal products. This year's global campaign involves medicines authorities from 82 countries and highlights the important role of every healthcare professional, patient and caregiver who reports a suspected adverse reaction, thus contributing to the safe use of medicinal products.
All medicinal products can cause adverse reactions. The FAMHP monitors all medicinal products, even after they have been placed on the market. The aim is to get more information about known adverse reactions and discover new ones. The FAMHP and international partners analyse all reports to protect current and future patients.
By reporting suspected adverse reactions to the FAMHP, you are actively participating in identifying new safety issues. Both patients and healthcare professionals can report adverse reactions at www.eenbijwerkingmelden.be or www.notifieruneffetindesirable.be.
Xavier De Cuyper, CEO of the FAMHP
"Every report by a patient or healthcare professional improves knowledge about the benefits and risks of medicinal products. They help us to take action to minimise risks."